13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 38 holding rows worth $721,561,000.
- Accession
- 0000930413-18-002592
- Filer
- CIK 1281446
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 44 entries on the cover page, a total value of $721,561,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $721,561,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,568,500 | $52,906,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,627,110 | $47,813,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 3,485,745 | $44,618,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 7,478,275 | $42,851,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 500,000 | $41,380,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 758,000 | $36,778,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 3,500,000 | $35,805,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 770,400 | $34,822,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 2,000,000 | $30,540,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,334,793 | $28,725,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 602,200 | $27,219,000 | thousands by filing date | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 552,300 | $26,798,000 | thousands by filing date | put |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 260,100 | $25,617,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 4,781,708 | $23,956,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 713,998 | $22,348,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 1,260,000 | $19,921,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 169,639 | $19,195,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 730,010 | $14,264,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 110,506 | $13,719,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 1,174,541 | $13,296,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 302,000 | $13,167,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,444,481 | $11,989,000 | thousands by filing date | |
| CORSICANTO II DESIGNATED ACT | 220485AB2 | NOTE 3.500% 1/2 | 10,000,000 | $10,900,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 500,000 | $10,760,000 | thousands by filing date | call |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,473,609 | $9,903,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,407,840 | $9,644,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 200,000 | $9,040,000 | thousands by filing date | put |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 2,988,716 | $8,458,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 1,537,020 | $7,654,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 2,280,921 | $6,752,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 107,900 | $5,235,000 | thousands by filing date | call |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,596,200 | $4,932,000 | thousands by filing date | call |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 145,900 | $4,187,000 | thousands by filing date | call |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,056,825 | $3,266,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 759,494 | $2,506,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 804,483 | $405,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 130,137 | $183,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 2,500 | $9,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-18-002592 | this filing | 2018-08-14 | acceptance time not in the bulk data set |